Medtech Start-Ups in Strategic Landscape of Abbott, Boston Scientific

Published on Jun 24, 2020


Smiths Medical acquires vascular access and infection prevention startup Access Scientific
Access Scientific manufactured the Powerwand, a family of midline and extended dwell catheters. Prior to its acquisition, Access Scientific had raised approximately $21.4M. The value of the acquisition was undisclosed.


 Start a Free Trial to Medtech Start-Up Tracker Today

Augmented reality (AR) surgical guidance system developer,
Augmedics, raises $15M in Series B round
The company’s first product, the xvision-spine system, received 510(k) clearance from the FDA in December 2019. With the latest round of fundraising, the company has raised $25.1M. Major strategics have yet to make a committed move to acquire AR startups. Other competitors in this space include EchoPixel, SentiAr, and MediView XR.

is developing a novel shunt system for the treatment of communicating hydrocephalus
In June 2020, CereVasc completed a Series A round raising $44M in capital from two investors – ATON Partners and Perceptive Advisors. The company is developing the eShunt System, a minimally invasive CSF shunt. Key strategics in this market include B. Braun and Medtronic.

Graphene-based neural interfaces are being developed by
INBRAIN Neuroelectronics
The company is developing an alternative to metal-based brain interfaces for neuromodular devices using graphene. Two Spanish investment groups recently invested $1.2M in the company in a Seed round. The neuromodulation devices market is steadily growing due to the demand for alternative therapies to treat drug-resistant neurological diseases. Key strategics in this market include Medtronic, Abbott, and LivaNova.

Okami Medical
is manufacturing the FDA-cleared LOBO Vascular Occluder
The company recently raised $7.2M to support the commercialization of its low-profile emobolic device which features the company’s proprietary HDBraid technology. The minimally invasive cardiovascular devices market is one of the largest medtech markets, with major competitors such as Abbott, Boston Scientific, and Medtronic.

Contraline is developing a reversible contraceptive device for men
Adam is a minimally invasive hydrogel device that is non-hormonal, long-lasting, and easily reversible. The company recently completed a Series A round for an undisclosed amount of money. The Series A round was led by FundRx.

A smart N95 respirator is in development from
The Breathio mask combines a UV-disinfector, breathing assistance system, and an advanced analytical system to monitor breathing and vital parameters. The company was founded in March 2020 in response to the global COVID-19 pandemic. Major competitors in the respiratory products market include 3M, Honeywell, and Moldex-Metric, among others.

Track the companies driving innovation in medtech by starting a trial to LSI's Medtech Start-Up Tracker.

Join us at the next LSI Emerging Medtech Summit

LSI's global events attract top innovators, active investors, and deal-making strategics.


Our Clients